Vasundhara Rasayans FY26 net profit rises 36% to ₹578.91 lakh

2 min read     Updated on 30 May 2026, 10:34 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vasundhara Rasayans reported a 36.3% rise in FY26 net profit to ₹578.91 lakh, with revenue increasing to ₹3,572.31 lakh. Q4 net profit surged to ₹247.82 lakh from ₹44.63 lakh. The Board appointed Shri Ravi Jain as an Additional Director and approved a manufacturing agreement with PandJ Cretechem Private Limited.

powered bylight_fuzz_icon
41526292

*this image is generated using AI for illustrative purposes only.

Vasundhara Rasayans reported a 36.3% rise in net profit to ₹578.91 lakh for the financial year ended March 31, 2026, compared to ₹424.63 lakh in the prior year. Revenue from operations for FY26 increased to ₹3,572.31 lakh from ₹3,399.01 lakh in FY25. The company’s statutory auditors, M/s. Mamta Jain & Associates, issued an unmodified opinion on the audited financial results.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹247.82 lakh, a significant increase from ₹44.63 lakh in the corresponding quarter of the previous year. Total income for the quarter stood at ₹1,258.38 lakh, up from ₹858.80 lakh in Q4FY25. Earnings per share (EPS) for the full year improved to ₹18.22 from ₹13.36 in the previous year.

The Board of Directors, at its meeting held on May 28, 2026, approved the audited standalone financial results. Based on the recommendation of the Nomination and Remuneration Committee, the Board appointed Shri Ravi Jain as an Additional Director (Non-Executive Independent Director) effective May 28, 2026, for a term of five years subject to shareholder approval. Mr. Ravi Jain is a Graduate with over 10 years of experience in marketing and business development across consumer goods. He has led strategic marketing, brand-building, and customer-acquisition initiatives, and is not related to any other Director on the Board.

Mr. Pradeep Kumar Jain retired as a Non-Executive Independent Director upon completing his second term of five consecutive years. In a strategic move, the Board approved entering into a Memorandum of Understanding cum Loan-Lease Agreement with PandJ Cretechem Private Limited, the holding company. This agreement establishes a manufacturing arrangement for Active Pharmaceutical Ingredients (APIs) at the holding company's facility in Dahej, Gujarat. The Audit Committee had previously approved and recommended this transaction on May 28, 2026.

The Board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, appointing Mr. Manish Jain as the chairperson of each committee effective May 29, 2026.

Financial Results for FY26

Particulars Year Ended 31.03.2026 (₹ in Lakhs) Year Ended 31.03.2025 (₹ in Lakhs)
Net Sales/Income from Operations 3,572.31 3,399.01
Total Income 3,862.69 3,634.09
Total Expenses 3,076.34 3,057.36
Profit before tax 786.35 576.73
Net Profit 578.91 424.63
Earnings Per Share (Basic) 18.22 13.36

Historical Stock Returns for Vasundhara Rasayans

1 Day5 Days1 Month6 Months1 Year5 Years
-1.98%+31.90%+22.47%-19.88%-23.78%+68.64%

How will the new manufacturing arrangement with PandJ Cretechem impact Vasundhara Rasayans' production capacity and cost structure?

What specific strategic value will Mr. Ravi Jain's marketing background bring to the company's future growth plans?

Can the significant surge in Q4 net profit be sustained into the next financial year, or was it driven by one-off factors?

Vasundhara Rasayans to consider Q4, FY26 results on May 28

1 min read     Updated on 20 May 2026, 06:48 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Vasundhara Rasayans Limited will hold a board meeting on May 28, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The trading window is closed for designated persons until 48 hours post-result declaration.

powered bylight_fuzz_icon
40828668

*this image is generated using AI for illustrative purposes only.

Vasundhara Rasayans Limited has announced that its board of directors will meet on Thursday, May 28, 2026. The primary agenda for the meeting is to consider and approve the audited financial results for the quarter and fiscal year ended March 31, 2026.

The meeting is being convened in accordance with Regulation 29 of the SEBI (LODR) Regulations, 2015. The board will review the company's performance for the fourth quarter of the fiscal year 2026 and the annual financial statements for the full fiscal year.

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has stated that the trading window for dealing in equity shares is currently closed. This restriction applies to all designated persons, their immediate relatives, and other connected persons.

The window will remain shut until the conclusion of 48 hours after the declaration of the financial results for the quarter and year ended March 31, 2026. This measure is intended to ensure market integrity and prevent the misuse of unpublished price-sensitive information.

Meeting Details

Detail Information
Company Name Vasundhara Rasayans Limited
Meeting Date May 28, 2026
Purpose Audited Financial Results for Q4 and FY26
Fiscal Year End March 31, 2026

The notice, signed by Whole Time Director Sunil Kumar Jain, was dispatched to the stock exchanges on May 20, 2026, for information and necessary records.

Historical Stock Returns for Vasundhara Rasayans

1 Day5 Days1 Month6 Months1 Year5 Years
-1.98%+31.90%+22.47%-19.88%-23.78%+68.64%

How might Vasundhara Rasayans Limited's FY26 revenue and profit margins compare to the previous fiscal year, given current trends in the specialty chemicals sector?

Will the board consider announcing a dividend or any capital allocation strategy alongside the FY26 financial results on May 28?

How could the company's FY26 performance influence its future expansion plans or capital expenditure outlook in the rasayans/chemicals industry?

More News on Vasundhara Rasayans

1 Year Returns:-23.78%